This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ropponen, K. Articles by Kosma, V.-M. Search for Related Content PubMed Articles by Ropponen, K. Articles by Kosma, V.-M.

Tumor Cell-associated Hyaluronan as an Unfavorable Prognostic Factor in Colorectal Cancer¹

Departments of Pathology and Forensic Medicine [K. R., J. P., P. L., V-M. K.] and Anatomy [M. T., R. T., U. Å.], University of Kuopio, and Departments of Surgery [M. E., E. A.] and Pathology [J. P., V-M. K.], Kuopio University Hospital, FIN-70211 Kuopio, Finland

Hyaluronan (HA) is a linear high molecular weight extracellular polysaccharide. It is thought to be involved in mitosis and the enhancement of wound healing, tumor invasion, and metastasis. Because its clinical relevance in cancer has not been explored, we scored HA in colorectal adenocarcinoma and studied its relationship with patient survival. A specific probe prepared from cartilage proteoglycan aggregates was used to stain paraffin-embedded tumor samples from 202 colorectal adenocarcinoma patients treated in Kuopio University Hospital and followed up for a mean of 14 years. The hypothesis that the percentage of HA-positive carcinoma cells (HA%) and HA intensity in cancer cells correlated with survival was tested with the log-rank test, hazard ratios, and their confidence intervals. Ninety-three % of tumors had at least a proportion of carcinoma cells positive for HA. HA intensity in tumor epithelium was stronger in Dukes' stages C and D tumors and in high-grade tumors. The cancer-related survival rate was lower among patients with strong HA intensity in tumor epithelium (P < 0.001) and high HA% (P < 0.001). Recurrence-free survival was also shorter in patients with an intense signal for HA (P = 0.001) and high HA% in tumor epithelium (P = 0.04). HA intensity in tumor epithelium independently predicted survival and recurrence-free survival (Cox's analysis). We conclude that a high proportion of HA-positive cancer cells and high intensity of the HA-signal predicts a poor survival rate. The abnormal expression of HA in the neoplastic colon epithelial cells is suggested to provide a distinct advantage for invasive growth and metastasis.

¹ This study was financially supported by the North Savo Cancer Fund and the EVO funds of Kuopio University Hospital.

² To whom requests for reprints should be addressed, at Department of Pathology and Forensic Medicine, University of Kuopio, P. O. Box 1627, FIN-70211 Kuopio, Finland. Phone: 358-17-162 750; Fax: 358-17-162 753; E-mail: VeliMatti.Kosma @uku.fi.

Received 7/21/97. Accepted 11/13/97.

This article has been cited by other articles:

				A. V. Ivanova, C. M.V. Goparaju, S. V. Ivanov, D. Nonaka, C. Cruz, A. Beck, F. Lonardo, A. Wali, and H. I. Pass Protumorigenic Role of HAPLN1 and Its IgV Domain in Malignant Pleural Mesothelioma Clin. Cancer Res., April 15, 2009; 15(8): 2602 - 2611. [Abstract] [Full Text] [PDF]

				N. Itano Simple Primary Structure, Complex Turnover Regulation and Multiple Roles of Hyaluronan J. Biochem., August 1, 2008; 144(2): 131 - 137. [Abstract] [Full Text] [PDF]

				P. Karihtala, Y. Soini, P. Auvinen, R. Tammi, M. Tammi, and V.-M. Kosma Hyaluronan in Breast Cancer: Correlations With Nitric Oxide Synthases and Tyrosine Nitrosylation J. Histochem. Cytochem., December 1, 2007; 55(12): 1191 - 1198. [Abstract] [Full Text] [PDF]

				K. Hosono, Y. Nishida, W. Knudson, C. B. Knudson, T. Naruse, Y. Suzuki, and N. Ishiguro Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells Am. J. Pathol., July 1, 2007; 171(1): 274 - 286. [Abstract] [Full Text] [PDF]

				A. Kultti, K. Rilla, R. Tiihonen, A. P. Spicer, R. H. Tammi, and M. I. Tammi Hyaluronan Synthesis Induces Microvillus-like Cell Surface Protrusions J. Biol. Chem., June 9, 2006; 281(23): 15821 - 15828. [Abstract] [Full Text] [PDF]

				K. N. Sugahara, T. Hirata, H. Hayasaka, R. Stern, T. Murai, and M. Miyasaka Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments J. Biol. Chem., March 3, 2006; 281(9): 5861 - 5868. [Abstract] [Full Text] [PDF]

				V. B. Lokeshwar, W. H. Cerwinka, and B. L. Lokeshwar HYAL1 Hyaluronidase: A Molecular Determinant of Bladder Tumor Growth and Invasion Cancer Res., March 15, 2005; 65(6): 2243 - 2250. [Abstract] [Full Text] [PDF]

				H.-R. Kim, M. A. Wheeler, C. M. Wilson, J. Iida, D. Eng, M. A. Simpson, J. B. McCarthy, and K. M. Bullard Hyaluronan Facilitates Invasion of Colon Carcinoma Cells in Vitro via Interaction with CD44 Cancer Res., July 1, 2004; 64(13): 4569 - 4576. [Abstract] [Full Text] [PDF]

				B. J. Sommer, J. J. Barycki, and M. A. Simpson Characterization of Human UDP-glucose Dehydrogenase: CYS-276 IS REQUIRED FOR THE SECOND OF TWO SUCCESSIVE OXIDATIONS J. Biol. Chem., May 28, 2004; 279(22): 23590 - 23596. [Abstract] [Full Text] [PDF]

				N. Itano, T. Sawai, F. Atsumi, O. Miyaishi, S. Taniguchi, R. Kannagi, M. Hamaguchi, and K. Kimata Selective Expression and Functional Characteristics of Three Mammalian Hyaluronan Synthases in Oncogenic Malignant Transformation J. Biol. Chem., April 30, 2004; 279(18): 18679 - 18687. [Abstract] [Full Text] [PDF]

				K. M. Stuhlmeier and C. Pollaschek Differential Effect of Transforming Growth Factor {beta} (TGF-{beta}) on the Genes Encoding Hyaluronan Synthases and Utilization of the p38 MAPK Pathway in TGF-{beta}-induced Hyaluronan Synthase 1 Activation J. Biol. Chem., March 5, 2004; 279(10): 8753 - 8760. [Abstract] [Full Text] [PDF]

				B. Mytar, M. Woloszyn, R. Szatanek, M. Baj-Krzyworzeka, M. Siedlar, I. Ruggiero, J. Wieckiewicz, and M. Zembala Tumor cell-induced deactivation of human monocytes J. Leukoc. Biol., December 1, 2003; 74(6): 1094 - 1101. [Abstract] [Full Text]

				A. Zoltan-Jones, L. Huang, S. Ghatak, and B. P. Toole Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells J. Biol. Chem., November 14, 2003; 278(46): 45801 - 45810. [Abstract] [Full Text] [PDF]

				S. Sillanpaa, M. A. Anttila, K. Voutilainen, R. H. Tammi, M. I. Tammi, S. V. Saarikoski, and V.-M. Kosma CD44 Expression Indicates Favorable Prognosis in Epithelial Ovarian Cancer Clin. Cancer Res., November 1, 2003; 9(14): 5318 - 5324. [Abstract] [Full Text] [PDF]

				K. N. Sugahara, T. Murai, H. Nishinakamura, H. Kawashima, H. Saya, and M. Miyasaka Hyaluronan Oligosaccharides Induce CD44 Cleavage and Promote Cell Migration in CD44-expressing Tumor Cells J. Biol. Chem., August 22, 2003; 278(34): 32259 - 32265. [Abstract] [Full Text] [PDF]

				J. T. Posey, M. S. Soloway, S. Ekici, M. Sofer, F. Civantos, R. C. Duncan, and V. B. Lokeshwar Evaluation of the Prognostic Potential of Hyaluronic Acid and Hyaluronidase (HYAL1) for Prostate Cancer Cancer Res., May 15, 2003; 63(10): 2638 - 2644. [Abstract] [Full Text] [PDF]

				K. Rilla, M. J. Lammi, R. Sironen, K. Torronen, M. Luukkonen, V. C. Hascall, R. J. Midura, M. Hyttinen, J. Pelkonen, M. Tammi, et al. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes J. Cell Sci., September 15, 2002; 115(18): 3633 - 3643. [Abstract] [Full Text] [PDF]

				V. B. Lokeshwar, G. L. Schroeder, R. I. Carey, M. S. Soloway, and N. Iida Regulation of Hyaluronidase Activity by Alternative mRNA Splicing J. Biol. Chem., September 6, 2002; 277(37): 33654 - 33663. [Abstract] [Full Text] [PDF]

				M. A. Simpson, C. M. Wilson, and J. B. McCarthy Inhibition of Prostate Tumor Cell Hyaluronan Synthesis Impairs Subcutaneous Growth and Vascularization in Immunocompromised Mice Am. J. Pathol., September 1, 2002; 161(3): 849 - 857. [Abstract] [Full Text] [PDF]

				Y. Zhang, A. A. Thant, K. Machida, Y. Ichigotani, Y. Naito, Y. Hiraiwa, T. Senga, Y. Sohara, S. Matsuda, and M. Hamaguchi Hyaluronan-CD44s Signaling Regulates Matrix Metalloproteinase-2 Secretion in a Human Lung Carcinoma Cell Line QG90 Cancer Res., July 15, 2002; 62(14): 3962 - 3965. [Abstract] [Full Text] [PDF]

				T. Yang, T. F. Witham, L. Villa, M. Erff, J. Attanucci, S. Watkins, D. Kondziolka, H. Okada, I. F. Pollack, and W. H. Chambers Glioma-associated Hyaluronan Induces Apoptosis in Dendritic Cells via Inducible Nitric Oxide Synthase: Implications for the Use of Dendritic Cells for Therapy of Gliomas Cancer Res., May 1, 2002; 62(9): 2583 - 2591. [Abstract] [Full Text] [PDF]

				N. Tsuchiya, Y. Kondo, A. Takahashi, H. Pawar, J. Qian, K. Sato, M. M. Lieber, and R. B. Jenkins Mapping and Gene Expression Profile of the Minimally Overrepresented 8q24 Region in Prostate Cancer Am. J. Pathol., May 1, 2002; 160(5): 1799 - 1806. [Abstract] [Full Text] [PDF]

				B. P. Toole Hyaluronan promotes the malignant phenotype Glycobiology, March 1, 2002; 12(3): 37R - 42R. [Abstract] [Full Text] [PDF]

				B. P. Toole, T. N. Wight, and M. I. Tammi Hyaluronan-Cell Interactions in Cancer and Vascular Disease J. Biol. Chem., February 8, 2002; 277(7): 4593 - 4596. [Full Text] [PDF]

				Y. Sohara, N. Ishiguro, K. Machida, H. Kurata, A. A. Thant, T. Senga, S. Matsuda, K. Kimata, H. Iwata, and M. Hamaguchi Hyaluronan Activates Cell Motility of v-Src-transformed Cells via Ras-Mitogen-activated Protein Kinase and Phosphoinositide 3-Kinase-Akt in a Tumor-specific Manner Mol. Biol. Cell, June 1, 2001; 12(6): 1859 - 1868. [Abstract] [Full Text] [PDF]

				R. M. Peterson, Q. Yu, I. Stamenkovic, and B. P. Toole Perturbation of Hyaluronan Interactions by Soluble CD44 Inhibits Growth of Murine Mammary Carcinoma Cells in Ascites Am. J. Pathol., June 1, 2000; 156(6): 2159 - 2167. [Abstract] [Full Text] [PDF]

				P. Auvinen, R. Tammi, J. Parkkinen, M. Tammi, U. Agren, R. Johansson, P. Hirvikoski, M. Eskelinen, and V.-M. Kosma Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts Survival Am. J. Pathol., February 1, 2000; 156(2): 529 - 536. [Abstract] [Full Text] [PDF]

				M. A. Anttila, R. H. Tammi, M. I. Tammi, K. J. Syrjänen, S. V. Saarikoski, and V.-M. Kosma High Levels of Stromal Hyaluronan Predict Poor Disease Outcome in Epithelial Ovarian Cancer Cancer Res., January 1, 2000; 60(1): 150 - 155. [Abstract] [Full Text]

				T. Fujisaki, Y. Tanaka, K. Fujii, S. Mine, K. Saito, S. Yamada, U. Yamashita, T. Irimura, and S. Eto CD44 Stimulation Induces Integrin-mediated Adhesion of Colon Cancer Cell Lines to Endothelial Cells by Up-Regulation of Integrins and c-Met and Activation of Integrins Cancer Res., September 1, 1999; 59(17): 4427 - 4434. [Abstract] [Full Text] [PDF]

				V. B. Lokeshwar, M. J. Young, G. Goudarzi, N. Iida, A. I. Yudin, G. N. Cherr, and M. G. Selzer Identification of Bladder Tumor-derived Hyaluronidase: Its Similarity to HYAL1 Cancer Res., September 1, 1999; 59(17): 4464 - 4470. [Abstract] [Full Text] [PDF]

				N. Itano, T. Sawai, O. Miyaishi, and K. Kimata Relationship between Hyaluronan Production and Metastatic Potential of Mouse Mammary Carcinoma Cells Cancer Res., May 1, 1999; 59(10): 2499 - 2504. [Abstract] [Full Text] [PDF]

				K. Lessan, D. J. Aguiar, T. Oegema, L. Siebenson, and A. P. N. Skubitz CD44 and ß1 Integrin Mediate Ovarian Carcinoma Cell Adhesion to Peritoneal Mesothelial Cells Am. J. Pathol., May 1, 1999; 154(5): 1525 - 1537. [Abstract] [Full Text] [PDF]

				R. Kosaki, K. Watanabe, and Y. Yamaguchi Overproduction of Hyaluronan by Expression of the Hyaluronan Synthase Has2 Enhances Anchorage-independent Growth and Tumorigenicity Cancer Res., March 1, 1999; 59(5): 1141 - 1145. [Abstract] [Full Text] [PDF]

				W Hayen, M Goebeler, S Kumar, R Riessen, and V Nehls Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture J. Cell Sci., January 7, 1999; 112(13): 2241 - 2251. [Abstract] [PDF]

				J.-P. Pienimaki, K. Rilla, C. Fulop, R. K. Sironen, S. Karvinen, S. Pasonen, M. J. Lammi, R. Tammi, V. C. Hascall, and M. I. Tammi Epidermal Growth Factor Activates Hyaluronan Synthase 2 in Epidermal Keratinocytes and Increases Pericellular and Intracellular Hyaluronan J. Biol. Chem., June 1, 2001; 276(23): 20428 - 20435. [Abstract] [Full Text] [PDF]

				V. B. Lokeshwar, D. Rubinowicz, G. L. Schroeder, E. Forgacs, J. D. Minna, N. L. Block, M. Nadji, and B. L. Lokeshwar Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer J. Biol. Chem., April 6, 2001; 276(15): 11922 - 11932. [Abstract] [Full Text] [PDF]

				M. A. Simpson, J. Reiland, S. R. Burger, L. T. Furcht, A. P. Spicer, T. R. Oegema Jr., and J. B. McCarthy Hyaluronan Synthase Elevation in Metastatic Prostate Carcinoma Cells Correlates with Hyaluronan Surface Retention, a Prerequisite for Rapid Adhesion to Bone Marrow Endothelial Cells J. Biol. Chem., May 18, 2001; 276(21): 17949 - 17957. [Abstract] [Full Text] [PDF]